Xiaoling Wu

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Jesús G. Berdeja, Deepu Madduri, Saad Z. Usmani et al. · The Lancet · 2021 · 1.5K citations

Hematological Malignancy, Cell Therapy, Immunotherapy +11

Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder

Vladimir Coric, Howard Feldman, Dan A. Oren et al. · Depression and Anxiety · 2010 · 171 citations · Full text

Dry sliding friction and wear properties of B4C particulate-reinforced Al-5083 matrix composites

Feng Tang, Xiaoling Wu, Shirong Ge et al. · Wear · 2007 · 166 citations

Materials Science, Metal Matrix Composite, Engineering +7

Chinese version of the Perceived Stress Scale-10: A psychometric study in Chinese university students

Wei Lu, Qian Bian, Wenzheng Wang et al. · PLoS ONE · 2017 · 164 citations · Full text

Psychological Co-morbidities, Education, Psychometrics +16

CARTITUDE-1: Phase 1b/2 Study of Ciltacabtagene Autoleucel, a B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T Cell Therapy, in Relapsed/Refractory Multiple Myeloma

Deepu Madduri, Jesús G. Berdeja, Saad Z. Usmani et al. · Blood · 2020 · 92 citations